On behalf of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National Cancer Institute (NCI) we would like to thank those who participated in the NCI-SNMMI Workshop on Targeted Radionuclide Therapy held October 24-25, 2014 at the National Institute of Health (NIH) in Bethesda, Maryland. As with the first workshop on targeted radionuclide therapy (TRT) held in March 2013, the purpose of this workshop was to stimulate discussion on the current and potential applications of TRT for the treatment of hematologic and solid cancers. The second workshop was more focused than the first in that it looked at the lessons learned from prior experiences, the most promising approaches moving forward and the challenges inherent to bringing TRT to the clinic. The final schedule included didactic lectures, panel discussions and break-out sessions followed by a summary of progress and a discussion of future directions. The 2-day workshop brought together individuals from multiple scientific disciplines in an instructive and collaborative environment and included representatives from the NCI, industry and the academic community.
The final day of the workshop included a summary of progress and provided an outline of future directions. The areas highlighted included the need for:
We are currently working to develop an executive summary as well as a comprehensive report from the meeting. This information, as well as the final presentations from the speakers will be posted on this website in the coming weeks.
For additional information regarding the 2014 workshop, please access the links below: